Saleh Alqahtani

Medicine & Life Sciences

1. Saudi Arabia 100%
2. Liver Transplantation 82%
3. Non-alcoholic Fatty Liver Disease 80%
4. Coronavirus 64%
5. Liver Diseases 52%
6. Hepatocellular Carcinoma 31%
7. Hepacivirus 30%
8. Liver 29%
9. Fibrosis 27%
10. Mortality 27%
11. Pandemics 26%
12. Obesity 24%
13. Fatty Liver 19%
14. Tissue Donors 19%
15. Population 18%
16. Severe Acute Respiratory Syndrome 18%
17. Hepatitis C 17%
18. SARS Virus 16%
19. Critical Illness 16%
20. Chronic Disease 16%
21. Transplants 16%
22. Type 2 Diabetes Mellitus 15%
23. Confidence Intervals 15%
24. Therapeutics 15%
25. Ribavirin 14%
26. Health 14%
27. Cohort Studies 13%
28. Artificial Intelligence 13%
29. Living Donors 13%
30. Virus Diseases 13%
31. Registries 13%
32. Liver Cirrhosis 12%
33. Liver Neoplasms 12%
34. Intensive Care Units 12%
35. Public Health 12%
36. Transplant Recipients 11%
37. Sedentary Behavior 11%
38. Odds Ratio 11%
39. Chronic Hepatitis C 11%
40. Epidemiology 10%
41. Gastroenterology 10%
42. Hepatitis B 10%
43. Antiviral Agents 10%
44. Genotype 10%
45. Global Burden of Disease 10%
46. Hepatitis B virus 10%
47. Systematic Reviews 10%
48. Chronic Hepatitis B 10%
49. Cross-Sectional Studies 9%
50. End Stage Liver Disease 9%